Latamoxef: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Tags: mobile edit mobile web edit
 
Line 1: Line 1:
'''Latamoxef''' (or '''moxalactam''') is an [[antibiotic]] in the [[cephalosporin]] class. It is an oxacephem, a subclass of beta-lactam antibiotics that includes [[flomoxef]] and [[cefoperazone]]. Latamoxef was discovered by scientists at [[Shionogi]].
== Latamoxef ==


==Medical uses==
[[File:Moxalactam_synthesis.svg|thumb|right|Synthesis of Moxalactam]]
Latamoxef is used to treat severe infections caused by susceptible strains of [[microorganism]]s. It is particularly effective against [[gram-negative bacteria]], including [[Pseudomonas aeruginosa]], [[Escherichia coli]], and [[Klebsiella pneumoniae]]. It is also used in the treatment of [[septicemia]], [[meningitis]], and infections of the [[urinary tract]], [[respiratory tract]], [[skin and skin structure]], and [[intra-abdominal]] region.


==Pharmacology==
'''Latamoxef''', also known as '''moxalactam''', is a [[beta-lactam antibiotic]] belonging to the [[oxacephem]] class. It is used in the treatment of various bacterial infections and is known for its broad-spectrum activity against both [[Gram-positive bacteria|Gram-positive]] and [[Gram-negative bacteria]].
Latamoxef is a broad-spectrum antibiotic that inhibits the synthesis of bacterial cell walls, leading to cell death. It is resistant to most beta-lactamases and is active against a wide range of gram-negative and gram-positive bacteria.


==Side effects==
== Mechanism of Action ==
Common side effects of latamoxef include [[diarrhea]], [[nausea]], [[vomiting]], and [[rash]]. Less common side effects include [[anemia]], [[thrombocytopenia]], and [[leukopenia]]. In rare cases, latamoxef can cause serious allergic reactions.


==History==
Latamoxef works by inhibiting bacterial [[cell wall]] synthesis. It binds to [[penicillin-binding proteins]] (PBPs) located inside the bacterial cell wall, which are essential for the cross-linking of the [[peptidoglycan]] layer. This inhibition leads to the weakening of the cell wall and ultimately causes bacterial cell lysis and death.
Latamoxef was discovered in the 1970s by scientists at Shionogi. It was approved for medical use in the United States in 1981.


==See also==
== Clinical Uses ==
* [[List of antibiotics]]
* [[Oxacephem]]
* [[Cephalosporin]]


Latamoxef is used to treat a variety of infections, including:
* [[Urinary tract infections]]
* [[Respiratory tract infections]]
* [[Intra-abdominal infections]]
* [[Skin and soft tissue infections]]
It is particularly useful in treating infections caused by [[Enterobacteriaceae]] and other resistant organisms.
== Side Effects ==
Common side effects of latamoxef include:
* [[Gastrointestinal disturbances]] such as [[nausea]] and [[diarrhea]]
* [[Allergic reactions]], including [[rash]] and [[anaphylaxis]]
* [[Hematological effects]] such as [[thrombocytopenia]] and [[neutropenia]]
== Synthesis ==
The synthesis of moxalactam involves the chemical modification of the beta-lactam core to include an oxacephem ring structure. This modification enhances its stability against beta-lactamases and broadens its antibacterial spectrum.
== Related Pages ==
* [[Beta-lactam antibiotics]]
* [[Antibiotic resistance]]
* [[Penicillin-binding proteins]]
[[Category:Beta-lactam antibiotics]]
[[Category:Antibiotics]]
[[Category:Antibiotics]]
[[Category:Cephalosporin antibiotics]]
[[Category:Shionogi]]
{{stub}}

Latest revision as of 11:00, 15 February 2025

Latamoxef[edit]

Synthesis of Moxalactam

Latamoxef, also known as moxalactam, is a beta-lactam antibiotic belonging to the oxacephem class. It is used in the treatment of various bacterial infections and is known for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria.

Mechanism of Action[edit]

Latamoxef works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, which are essential for the cross-linking of the peptidoglycan layer. This inhibition leads to the weakening of the cell wall and ultimately causes bacterial cell lysis and death.

Clinical Uses[edit]

Latamoxef is used to treat a variety of infections, including:

It is particularly useful in treating infections caused by Enterobacteriaceae and other resistant organisms.

Side Effects[edit]

Common side effects of latamoxef include:

Synthesis[edit]

The synthesis of moxalactam involves the chemical modification of the beta-lactam core to include an oxacephem ring structure. This modification enhances its stability against beta-lactamases and broadens its antibacterial spectrum.

Related Pages[edit]